Eligibility Breast Neoplasms NCT00039793

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
confirmed tissue diagnosis of cancer of the breast, ovary, prostate or colo-rectum
Description

ID.1

Data type

boolean

Alias
UMLS CUI [1]
C0678222
UMLS CUI [2,1]
C0006826
UMLS CUI [2,2]
C0029939
UMLS CUI [3]
C0600139
UMLS CUI [4]
C0699790
UMLS CUI [5,1]
C0006826
UMLS CUI [5,2]
C0034896
have an anticipated completion of chemotherapy no more than 2 weeks before the last bodywork session.
Description

ID.2

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0805732
have a primary oncologist
Description

ID.3

Data type

boolean

Alias
UMLS CUI [1]
C0259990
currently receiving chemotherapy or completed chemotherapy treatment within the past 6 months
Description

ID.4

Data type

boolean

Alias
UMLS CUI [1]
C0392920
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
active skin rash or open cutaneous lesions.
Description

ID.5

Data type

boolean

Alias
UMLS CUI [1]
C0015230
UMLS CUI [2,1]
C0221198
UMLS CUI [2,2]
C0221912
history of venous thrombosis (or symptomatic varicosity)
Description

ID.6

Data type

boolean

Alias
UMLS CUI [1]
C0042487
identification of a thrombosis using an ultrasound test of the legs.
Description

ID.7

Data type

boolean

Alias
UMLS CUI [1,1]
C0040053
UMLS CUI [1,2]
C1456803
long term (> 3 months) steroid medications for other medical conditions in past 5 years
Description

ID.8

Data type

boolean

Alias
UMLS CUI [1]
C0038317
plans to move out of the study region within 6 months
Description

ID.9

Data type

boolean

Alias
UMLS CUI [1,1]
C0337094
UMLS CUI [1,2]
C0008976
thyroid-stimulating hormone (tsh) level above the upper limit of normal
Description

ID.10

Data type

boolean

Alias
UMLS CUI [1]
C0202230
hematocrit <25%
Description

ID.11

Data type

boolean

Alias
UMLS CUI [1]
C0518014
platelet count of < 50,000
Description

ID.12

Data type

boolean

Alias
UMLS CUI [1]
C0005821
patients who have been receiving regular (i.e. at least twice a month) bodywork over the past 6 months.
Description

ID.13

Data type

boolean

Alias
UMLS CUI [1]
C0695540

Similar models

Eligibility Breast Neoplasms NCT00039793

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
confirmed tissue diagnosis of cancer of the breast, ovary, prostate or colo-rectum
boolean
C0678222 (UMLS CUI [1])
C0006826 (UMLS CUI [2,1])
C0029939 (UMLS CUI [2,2])
C0600139 (UMLS CUI [3])
C0699790 (UMLS CUI [4])
C0006826 (UMLS CUI [5,1])
C0034896 (UMLS CUI [5,2])
ID.2
Item
have an anticipated completion of chemotherapy no more than 2 weeks before the last bodywork session.
boolean
C0392920 (UMLS CUI [1,1])
C0805732 (UMLS CUI [1,2])
ID.3
Item
have a primary oncologist
boolean
C0259990 (UMLS CUI [1])
ID.4
Item
currently receiving chemotherapy or completed chemotherapy treatment within the past 6 months
boolean
C0392920 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ID.5
Item
active skin rash or open cutaneous lesions.
boolean
C0015230 (UMLS CUI [1])
C0221198 (UMLS CUI [2,1])
C0221912 (UMLS CUI [2,2])
ID.6
Item
history of venous thrombosis (or symptomatic varicosity)
boolean
C0042487 (UMLS CUI [1])
ID.7
Item
identification of a thrombosis using an ultrasound test of the legs.
boolean
C0040053 (UMLS CUI [1,1])
C1456803 (UMLS CUI [1,2])
ID.8
Item
long term (> 3 months) steroid medications for other medical conditions in past 5 years
boolean
C0038317 (UMLS CUI [1])
ID.9
Item
plans to move out of the study region within 6 months
boolean
C0337094 (UMLS CUI [1,1])
C0008976 (UMLS CUI [1,2])
ID.10
Item
thyroid-stimulating hormone (tsh) level above the upper limit of normal
boolean
C0202230 (UMLS CUI [1])
ID.11
Item
hematocrit <25%
boolean
C0518014 (UMLS CUI [1])
ID.12
Item
platelet count of < 50,000
boolean
C0005821 (UMLS CUI [1])
ID.13
Item
patients who have been receiving regular (i.e. at least twice a month) bodywork over the past 6 months.
boolean
C0695540 (UMLS CUI [1])